Closure of Trading Window for Quarter year ended on 30th June 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals has announced the closure of its trading window for the quarter ended 30th June 2025, in compliance with SEBI's Insider Trading Regulations. During this period, designated persons including directors, key managerial personnel, and other insiders are prohibited from trading in the company's shares. The window closure typically precedes the announcement of quarterly financial results, signaling that Q1 FY26 results are expected soon. This is a routine regulatory compliance measure and is mandatory for all listed companies ahead of results declaration.
No direct impact on the stock price. This is a standard compliance announcement that signals upcoming quarterly results, which could be a key catalyst for price movement once announced.